PTC Therapeutics Inc (NASDAQ:PTCT)

U.S. Markets are not yet open, but PTCT is being traded in the pre-market session. Pre-Market quote »
48.13
Delayed Data
As of Jun 30
 +0.70 / +1.48%
Today’s Change
22.70
Today|||52-Week Range
78.72
-7.03%
Year-to-Date
No recent news for PTC Therapeutics Inc.

Today’s Trading

Previous close47.43
Today’s open47.75
Day’s range-- - --
Volume371,116
Average volume (3 months)700,607
Market cap$1.6B
Dividend yield--
Data as of 06/30/2015

Growth & Valuation

Earnings growth (last year)+42.66%
Earnings growth (this year)-59.91%
Earnings growth (next 5 years)--
Revenue growth (last year)-27.24%
P/E ratioNM
Price/Sales--
Price/Book5.31

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...+3.07+6.19%
FOLDAmicus Therapeutics ...+0.52+3.82%
IRWDIronwood Pharmaceuti...+0.47+4.06%
TTPHTetraphase Pharmaceu...+4.27+9.89%
Data as of 06/30/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$25.2M
Annual profit (last year)-$93.8M
Net profit margin-371.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stuart W. Peltz
Executive VP-Research, Operations &
Technology
Neil Gregory Almstead
Corporate headquarters
South Plainfield, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers